Synergy between Medical Nutrition Therapy and Semaglutide: Dietary Insights One major concern during therapy is inadequate protein intake, which can impair muscle strength and function, thereby increasing the risk of weight regain through repeated cycles of weight loss and regain (yo-yo effect) [26]
PlexusDx compounded semaglutide injections begin at $189/mo (or $149/mo on the 6-month plan) with no flat per-compound pricing increases, making personalized therapy accessible while you manage multiple chronic conditions
K., Lingvay I., Srrig R., Treppendahl M
Association of B12 deficiency and clinical neuropathy with metformin use in type 2 diabetes patients
The dispersion between Novo and Lilly again goes to show the incredible power of competition to dictate stock outcomes: despite Novos excellent financial performance since 2023 (31% growth in 2023, 25% growth in 2024, 48% EBIT margins), the stock has declined because of competition: investors think Eli Lilly is the emerging winner within GLP-1s, given the stronger weight loss profile of tirzepatide (Mounjaro/Zepbound) versus semaglutide (Ozempic/Wegovy), and Lillys more attractive weight loss pipeline assets